Quick Answer
Viking Therapeutics, Inc. reported Stockholders Equity of $639.06 million for the year ending 2025.
- Viking Therapeutics, Inc. showed a decrease of -27.4% in Stockholders Equity from 2024 to 2025.
- This data is from Viking Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$27.84 million | Q2 2015: $17.39 million | Q3 2015: $13.27 million | Q1 2016: $5.77 million | Q2 2016: $12.79 million | Q3 2016: $10.22 million | Q1 2017: $7.55 million | Q2 2017: $6.59 million | Q3 2017: $2.23 million | Q1 2018: $72.63 million | Q2 2018: $140.36 million | Q3 2018: $302.05 million | Q1 2019: $294.57 million | Q2 2019: $288.35 million | Q3 2019: $283.49 million | Q1 2020: $268.28 million | Q2 2020: $261.95 million | Q3 2020: $253.79 million | Q1 2021: $237.22 million | Q2 2021: $224.97 million | Q3 2021: $213.12 million | Q1 2022: $182.27 million | Q2 2022: $165.23 million | Q3 2022: $151.29 million | Q1 2023: $134.07 million | Q2 2023: $386.12 million | Q3 2023: $368.24 million | Q1 2024: $933.89 million | Q2 2024: $920.98 million | Q3 2024: $911.45 million | Q1 2025: $846.92 million | Q2 2025: $795.46 million | Q3 2025: $713.03 million.
- Over the full 12 years of available data (2014 to 2025), Viking Therapeutics, Inc.'s Stockholders Equity has grown by 2,988.0%.
- Historical annual values: Fiscal year 2025: $639.06 million | Fiscal year 2024: $880.28 million | Fiscal year 2023: $348.42 million | Fiscal year 2022: $145.32 million | Fiscal year 2021: $201.88 million | Fiscal year 2020: $244.34 million | Fiscal year 2019: $277.12 million | Fiscal year 2018: $297.75 million | Fiscal year 2017: $13.46 million | Fiscal year 2016: $8.04 million | Fiscal year 2015: $8.72 million | Fiscal year 2014: -$22.13 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: